COST TO SOCIETY DUE TO UNDEREMPLOYMENT IN PERSONS WITH HEMOPHILIA A AND B - HEMOPHILIA UTILIZATION GROUP STUDY V (HUGS V)

被引：0
|
作者：
Niu, X. [1 ]
Poon, J. L. [1 ]
Riske, B. [2 ]
Baker, J. [3 ]
Ullman, M. [4 ]
Gwadry-Sridhar, F. [5 ]
Lou, M. [6 ]
Nichol, M. B. [1 ]
机构：
[1] Univ So Calif, Los Angeles, CA USA
[2] Univ Colorado Denver, Aurora, CO USA
[3] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA
[4] Univ Texas Hlth Sci Ctr Houston, Houston, TX USA
[5] Univ Western Ontario, London, ON, Canada
[6] USC Sch Pharm, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.574
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A119 / A120
页数：2
相关论文
共 50 条
  • [31] Hemophilia joint health score v2.1 in US adults with hemophilia in the pain, functional impairment, and quality of life (P-FiQ) study
    Hernandez, Grace
    Baumann, Kimberly
    Recht, Michael
    Neff, Anne
    Quon, Doris
    Kessler, Craig
    Wang, Michael
    Buckner, Tyler W.
    Boggio, Lisa
    Gut, Robert Z.
    Cooper, David L.
    Kempton, Christine L.
    [J]. HAEMOPHILIA, 2016, 22 : 92 - 93
  • [32] Use of ultrasound for assessment of musculoskeletal disease in persons with hemophilia: Results of an International Prophylaxis Study Group (IPSG) survey
    Doria, Andrea
    vonDrygalski, Annette
    Blanchette, Victor
    Chang, Eric
    Fischer, Kathelijn
    Gibikote, Sridhar
    Keshava, Shyamkumar
    Babyn, Paul
    Dover, Saunya
    Querol, Felipe
    [J]. HAEMOPHILIA, 2018, 24 : 128 - 129
  • [33] CHARACTERIZATION OF HEALTH CARE UTILIZATION AND COST OF HEMOPHILIA A AND B IN REAL-LIFE: A 4-YEAR FOLLOW-UP STUDY IN FINLAND
    Ventola, H.
    Jokelainen, J.
    Linna, M.
    Lepantalo, A.
    Ylisaukko-oja, T.
    Lassila, R.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A500 - A500
  • [34] Postoperative deep vein thrombosis in a patient with hemophilia B and factor R506Q (factor V Leiden)
    Pruthi, RK
    Heit, JA
    Green, MM
    Emiliusen, LM
    Nichols, WL
    Wilke, J
    Gastineau, DA
    Gilchrist, GS
    [J]. THROMBOSIS AND HAEMOSTASIS, 1999, : 127 - 127
  • [35] Medical costs and hospital utilization for hemophilia A and B urban inpatients in China: a national cross-sectional study
    Huang, Zhengwei
    Nicholas, Stephen
    Yang, Yong
    Chen, Xiaoping
    Maitland, Elizabeth
    Ma, Yong
    Shi, Xuefeng
    [J]. BMC HEALTH SERVICES RESEARCH, 2022, 22 (01)
  • [36] Medical costs and hospital utilization for hemophilia A and B urban inpatients in China: a national cross-sectional study
    Zhengwei Huang
    Stephen Nicholas
    Yong Yang
    Xiaoping Chen
    Elizabeth Maitland
    Yong Ma
    Xuefeng Shi
    [J]. BMC Health Services Research, 22
  • [37] Inhibitor incidence in previously untreated patients (PUPs) with hemophilia A and B - A prospective, multicenter study of the pediatric study group of the German, Swiss and Austrian Society of Thrombosis and Hemostatis (GTH)-.
    Kreuz, W
    Auerswald, G
    Budde, U
    Lenk, H
    [J]. BLOOD, 2001, 98 (11) : 535A - 535A
  • [38] The cost-effectiveness of gene therapy for severe hemophilia B: a microsimulation study from the United States perspective
    Bolous, Nancy S.
    Chen, Yichen
    Wang, Huiqi
    Davidoff, Andrew M.
    Devidas, Meenakshi
    Jacobs, Timothy W.
    Meagher, Michael M.
    Nathwani, Amit C.
    Neufeld, Ellis J.
    Piras, Bryan A.
    Rodriguez-Galindo, Carlos
    Reiss, Ulrike M.
    Bhakta, Nickhill
    [J]. BLOOD, 2021, 138 (18) : 1677 - 1690
  • [39] Known-group validity of patient-reported outcome instruments and hemophilia joint health score v2.1 in US adults with hemophilia: results from the Pain, Functional Impairment, and Quality of life (P-FiQ) study
    Buckner, Tyler W.
    Wang, Michael
    Cooper, David L.
    Iyer, Neeraj N.
    Kempton, Christine L.
    [J]. PATIENT PREFERENCE AND ADHERENCE, 2017, 11 : 1745 - 1753
  • [40] ECONOMIC BURDEN OF MODERATE AND SEVERE HEMOPHILIA A AND B IN SPAIN, REAL-WORLD EVIDENCE INSIGHTS FROM THE COST OF HEMOPHILIA IN EUROPE: A SOCIO-ECONOMIC SURVEY II (CHESS II) STUDY
    Peral, C.
    De Lossada Juste, A.
    Lwoff, N.
    Espinoza Camac, N.
    Martinez, N.
    Casado, M. A.
    Burke, T.
    Kane, A.
    Alvir, J.
    Thakkar, S.
    Grazzi, Ferri E.
    [J]. VALUE IN HEALTH, 2023, 26 (12) : S508 - S508
12345